Please login to the form below
Metrion Biosciences
This page shows the latest Metrion Biosciences news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: setback for Akcea/Ionis, Urovant adds gene therapy, Metrion gains funding
Metrion awarded £637k for ion channel drug discovery. UK biotech and contract research firm Metrion Biosciences has been awarded £637, 000 under the Innovate UK Biomedical Catalyst Primer Award scheme.
Latest news
More from news
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Metrion Biosciences adds to its board
Dr Barry Kenny and Dr Andrew Southan join the company. Metrion Biosciences, the specialist ion channel contract research and drug discovery group, has appointed Dr Barry Kenny and Dr Andrew Southan ... Dr Keith McCullagh, non-executive chairman of
-
Metrion Biosciences establishes scientific advisory board
Contract research organisation and drug discovery business Metrion Biosciences has established a scientific advisory board, which will provide strategic scientific guidance to the company. ... The board will also comprise of Professor Annette Dolphin,
-
Metrion Biosciences expands operations team
Dr Andrew Southan appointed head of commercial operations. Cambridge, UK-based Metrion Biosciences has appointed Dr Andrew Southan as head of commercial operations. ... Dr Marc Rogers, chief scientific officer at Metrion Biosciences, said: “Since
-
Enterprise Therapeutics appoints CEO
Dr Ford also brings experience from Ario Pharma, where he is currently chief executive officer and co-founder, and Metrion Biosciences, where he serves as co-owner and investor director.
More from appointments
Approximately 3 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Roche to acquire Carmot Therapeutics in deal worth up to $3.1bn
- Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas
- UK-India research project trialling easy-to-use UTI test to support fight against AMR
- Cancer Research UK and Guardant collaborate to advance cancer detection and treatment
- Give the gift of positive change
- Apple Vision Pro: challenges and opportunities for pharma
No results were found
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
